Please note our privacy policy
Is this email not displaying correctly?
View this email in your browser
LISAvienna logo
This photo shows Johannes Sarx and Philipp Hainzl

 
Dear Readers, 


the new edition of our Highlights folder is in print. We are happy to share the digital version with you today and introduce the main topics below.

Enjoy reading!

Johannes Sarx and Philipp Hainzl
LISAvienna Executive Board
 
Download the file now!
Click here to follow LISAvienna on Twitter.
Click here to follow LISAvienna on LinkedIn.
Click here to go to LISAvienna's website.
This photo shows the plague column in Vienna. It was erected after the Great Plague epidemic in 1679.

Photo: istock, VvoeVale


COVID-19: Tests and medicine candidates in the Vienna region


Austria’s life sciences sector is mobilizing against the SARS-CoV-2 pandemic. These efforts are part of the activities around the globe. In the new Highlights edition we introduce some products and product candidates from the Vienna region – the development of most of them has been facilitated with public funding.
 

Coronavirus diagnostics

  • Attoquant Diagnostics
  • EUCODIS Bioscience 
  • Ingenetix 
  • Lexogen
  • Technoclone 
  • RT-LAMP test
  • Vienna COVID-19 Detection Initiative (VCDI)

Medicines in the pipeline

  • APEIRON Biologics
  • Apeptico
  • CEBINA
  • G.ST Antivirals
  • Marinomed
  • F4 Pharma
  • Panoptes
  • Polymun Scientific
  • Takeda
  • Themis Bioscience
  • Valneva
  • Viravaxx
Please find a more comprehensive overview online:
https://www.lisavienna.at/life-sciences-in-vienna/covid-19/ 
This photo shows a young lady with blue gloves holding a protective mask in front of her face that looks like the Austrian flag.

Photo: istock, kovop58

 

Advancing SARS-CoV-2-related innovation in Austria


The Austrian Federal Government and the City of Vienna are investing in research, development and innovation that contribute to mastering the pandemic. The new Highlights folder lists some of the support schemes:
  • FWF: Urgent Funding SARS-CoV-2
  • FFG: Emergency Call for Research into COVID-19
  • aws Investment Bonus
  • WWTF: COVID-19 Rapid Response Funding
  • Vienna Business Agency: Innovate4Vienna 
Contact LISAvienna for a more detailed overview and for information on COVID-19 related business support in Austria. Please also explore opportunities listed here:
https://www.lisavienna.at/funding/corona/
This photo shows a researcher at work at a cell culture hood.

Photo: Vienna Business Agency / Tircza Podzeit


Welcome to the Startup Labs at the Vienna BioCenter!


Vienna is one of Europe’s leading metropolises for innovation in the life sciences. The Vienna Business Agency is now offering co-working labs and offices to facilitate start-up processes. The new Startup Labs are in high demand. The Highlights folder provides insights on some of the first users.
  • a:head bio
  • Ablevia biotech
  • G.ST Antivirals
  • Miti Biosystems
  • MyeloPro
  • Pregenerate
  • Proxygen
  • THT Biomaterials
  • QUANTRO Therapeutics
Are you interested in joining the Startup Labs? Follow this link to learn more about the co-working  labs:  
https://viennabusinessagency.at/property/working-space/labs-for-rent/ 
This image shows the logos of LISAvienna's owners.
Click here to follow LISAvienna on Twitter.
Click here to follow LISAvienna on LinkedIn.
Click here to go to LISAvienna's website.
Copyright © 2020 LISAvienna, All rights reserved.

Our mailing address is: office@LISAvienna.at

LISAvienna is a joint life science platform operated by austria wirtschaftsservice and the Vienna Business Agency. On behalf of the Austrian Federal Ministry for Digital and Economic Affairs and the City of Vienna, LISAvienna contributes to the advancement of life sciences in Vienna.

Our news review, our outlook on future events and our list of opportunities for funding and support are not exhaustive and LISAvienna accepts no liability for potential mistakes.

update your preferences | unsubscribe from this list.